Logo image of 6D81.DE

DUPONT DE NEMOURS INC (6D81.DE) Stock Fundamental Analysis

FRA:6D81 - US26614N1028 - Common Stock

64.78 EUR
+2.08 (+3.32%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

5

6D81 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 69 industry peers in the Chemicals industry. Both the profitability and the financial health of 6D81 get a neutral evaluation. Nothing too spectacular is happening here. 6D81 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

6D81 had positive earnings in the past year.
In the past year 6D81 had a positive cash flow from operations.
Of the past 5 years 6D81 4 years were profitable.
Each year in the past 5 years 6D81 had a positive operating cash flow.
6D81.DE Yearly Net Income VS EBIT VS OCF VS FCF6D81.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

6D81 has a Return On Assets (-0.53%) which is in line with its industry peers.
6D81 has a Return On Equity (-0.84%) which is in line with its industry peers.
With a Return On Invested Capital value of 4.27%, 6D81 perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 6D81 is below the industry average of 6.71%.
The last Return On Invested Capital (4.27%) for 6D81 is above the 3 year average (3.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.53%
ROE -0.84%
ROIC 4.27%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
6D81.DE Yearly ROA, ROE, ROIC6D81.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

6D81's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 16.47%, 6D81 belongs to the best of the industry, outperforming 88.41% of the companies in the same industry.
In the last couple of years the Operating Margin of 6D81 has grown nicely.
With a Gross Margin value of 37.34%, 6D81 perfoms like the industry average, outperforming 55.07% of the companies in the same industry.
In the last couple of years the Gross Margin of 6D81 has remained more or less at the same level.
Industry RankSector Rank
OM 16.47%
PM (TTM) N/A
GM 37.34%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
6D81.DE Yearly Profit, Operating, Gross Margins6D81.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 6D81 is destroying value.
Compared to 1 year ago, 6D81 has less shares outstanding
The number of shares outstanding for 6D81 has been reduced compared to 5 years ago.
Compared to 1 year ago, 6D81 has an improved debt to assets ratio.
6D81.DE Yearly Shares Outstanding6D81.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
6D81.DE Yearly Total Debt VS Total Assets6D81.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.09, we must say that 6D81 is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of 6D81 (1.09) is worse than 76.81% of its industry peers.
The Debt to FCF ratio of 6D81 is 5.43, which is a neutral value as it means it would take 6D81, 5.43 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 6D81 (5.43) is better than 71.01% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that 6D81 is not too dependend on debt financing.
The Debt to Equity ratio of 6D81 (0.23) is better than 71.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.43
Altman-Z 1.09
ROIC/WACC0.51
WACC8.37%
6D81.DE Yearly LT Debt VS Equity VS FCF6D81.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

6D81 has a Current Ratio of 1.41. This is a normal value and indicates that 6D81 is financially healthy and should not expect problems in meeting its short term obligations.
6D81 has a Current ratio of 1.41. This is in the lower half of the industry: 6D81 underperforms 65.22% of its industry peers.
A Quick Ratio of 0.94 indicates that 6D81 may have some problems paying its short term obligations.
6D81's Quick ratio of 0.94 is on the low side compared to the rest of the industry. 6D81 is outperformed by 63.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.94
6D81.DE Yearly Current Assets VS Current Liabilites6D81.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

6D81 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.63%, which is quite impressive.
The Earnings Per Share has been decreasing by -5.50% on average over the past years.
The Revenue has been growing slightly by 4.55% in the past year.
6D81 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.31% yearly.
EPS 1Y (TTM)25.63%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%15.46%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%2.71%

3.2 Future

The Earnings Per Share is expected to grow by 7.60% on average over the next years.
Based on estimates for the next years, 6D81 will show a small growth in Revenue. The Revenue will grow by 4.12% on average per year.
EPS Next Y11.45%
EPS Next 2Y9.84%
EPS Next 3Y9.68%
EPS Next 5Y7.6%
Revenue Next Year3.77%
Revenue Next 2Y4.06%
Revenue Next 3Y4.28%
Revenue Next 5Y4.12%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
6D81.DE Yearly Revenue VS Estimates6D81.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B
6D81.DE Yearly EPS VS Estimates6D81.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.87 indicates a correct valuation of 6D81.
Based on the Price/Earnings ratio, 6D81 is valued a bit cheaper than 71.01% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, 6D81 is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.31, the valuation of 6D81 can be described as correct.
71.01% of the companies in the same industry are more expensive than 6D81, based on the Price/Forward Earnings ratio.
6D81 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.87
Fwd PE 15.31
6D81.DE Price Earnings VS Forward Price Earnings6D81.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

6D81's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, 6D81 is valued a bit cheaper than 68.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.82
EV/EBITDA 11.26
6D81.DE Per share data6D81.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

6D81's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 6D81 may justify a higher PE ratio.
PEG (NY)1.47
PEG (5Y)N/A
EPS Next 2Y9.84%
EPS Next 3Y9.68%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.20%, 6D81 has a reasonable but not impressive dividend return.
6D81's Dividend Yield is a higher than the industry average which is at 3.06.
Compared to an average S&P500 Dividend Yield of 2.34, 6D81 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.2%

5.2 History

The dividend of 6D81 decreases each year by -33.98%.
Dividend Growth(5Y)-33.98%
Div Incr Years4
Div Non Decr Years4
6D81.DE Yearly Dividends per share6D81.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of 6D81 are negative and hence is the payout ratio. 6D81 will probably not be able to sustain this dividend level.
DP-340.72%
EPS Next 2Y9.84%
EPS Next 3Y9.68%
6D81.DE Yearly Income VS Free CF VS Dividend6D81.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

DUPONT DE NEMOURS INC

FRA:6D81 (8/22/2025, 7:00:00 PM)

64.78

+2.08 (+3.32%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners72.83%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap27.12B
Analysts81.54
Price Target76.1 (17.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.2%
Yearly Dividend1.29
Dividend Growth(5Y)-33.98%
DP-340.72%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.64%
Min EPS beat(2)2.3%
Max EPS beat(2)4.98%
EPS beat(4)4
Avg EPS beat(4)7.65%
Min EPS beat(4)2.3%
Max EPS beat(4)11.99%
EPS beat(8)7
Avg EPS beat(8)8.15%
EPS beat(12)10
Avg EPS beat(12)6.47%
EPS beat(16)14
Avg EPS beat(16)7.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.28%
Min Revenue beat(2)-2.43%
Max Revenue beat(2)-2.14%
Revenue beat(4)0
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)-2.14%
Revenue beat(8)2
Avg Revenue beat(8)-2.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.72%
Revenue beat(16)3
Avg Revenue beat(16)-4.29%
PT rev (1m)-1.35%
PT rev (3m)-2.58%
EPS NQ rev (1m)1.8%
EPS NQ rev (3m)-3.36%
EPS NY rev (1m)3.03%
EPS NY rev (3m)3.57%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)0.62%
Valuation
Industry RankSector Rank
PE 16.87
Fwd PE 15.31
P/S 2.5
P/FCF 23.82
P/OCF 16.09
P/B 1.37
P/tB 18.96
EV/EBITDA 11.26
EPS(TTM)3.84
EY5.93%
EPS(NY)4.23
Fwd EY6.53%
FCF(TTM)2.72
FCFY4.2%
OCF(TTM)4.03
OCFY6.22%
SpS25.94
BVpS47.45
TBVpS3.42
PEG (NY)1.47
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.53%
ROE -0.84%
ROCE 6.55%
ROIC 4.27%
ROICexc 4.54%
ROICexgc 16%
OM 16.47%
PM (TTM) N/A
GM 37.34%
FCFM 10.49%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
ROICexc(3y)3.85%
ROICexc(5y)3.28%
ROICexgc(3y)12.84%
ROICexgc(5y)9.92%
ROCE(3y)5.39%
ROCE(5y)4.66%
ROICexcg growth 3Y25.22%
ROICexcg growth 5Y11.83%
ROICexc growth 3Y9.23%
ROICexc growth 5Y14.61%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.43
Debt/EBITDA 1.63
Cap/Depr 53.18%
Cap/Sales 5.04%
Interest Coverage 250
Cash Conversion 59.85%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.94
Altman-Z 1.09
F-Score5
WACC8.37%
ROIC/WACC0.51
Cap/Depr(3y)55.14%
Cap/Depr(5y)53.03%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.63%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%15.46%
EPS Next Y11.45%
EPS Next 2Y9.84%
EPS Next 3Y9.68%
EPS Next 5Y7.6%
Revenue 1Y (TTM)4.55%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%2.71%
Revenue Next Year3.77%
Revenue Next 2Y4.06%
Revenue Next 3Y4.28%
Revenue Next 5Y4.12%
EBIT growth 1Y20%
EBIT growth 3Y0.11%
EBIT growth 5Y-0.66%
EBIT Next Year30.26%
EBIT Next 3Y14.59%
EBIT Next 5Y10.67%
FCF growth 1Y373.84%
FCF growth 3Y-3.02%
FCF growth 5YN/A
OCF growth 1Y97.48%
OCF growth 3Y-6.79%
OCF growth 5Y5.56%